Home Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
Article
Licensed
Unlicensed Requires Authentication

Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition

  • Jennifer W. Bea EMAIL logo , Nicole C. Wright , Patricia Thompson , Chengcheng Hu , Stefano Guerra and Zhao Chen
Published/Copyright: March 2, 2011

Abstract

Background: Interest in biomarker patterns and disease has led to the development of immunoassays that evaluate multiple analytes in parallel while using little sample. However, there are no current standards for multiplex configuration, validation, and quality. Thus, validation by platform, population, and question of interest is recommended. We sought to determine the best blood fraction for multiplex evaluation of circulating biomarkers in post-menopausal women, and to explore body composition phenotype discrimination by biomarkers.

Methods: Archived serum and plasma samples from a sample of healthy post-menopausal women with the highest (n=9) and lowest (n=11) percent lean mass, as determined by dual-energy X-ray absorptiometry, were used to measure 90 analytes using bead-based, suspension multiplex assays. Replicates of serum and plasma were analyzed in a random selection of four of these individuals.

Results: Ninety percent of the analytes were detectable for ≥50% of samples; when limited to these well detected analytes, mean replicate correlations for serum and plasma were 0.87 and 0.85, respectively. Serum had lower error rates discriminating phenotypes; seven serum vs. two plasma analytes discriminated extreme body phenotypes.

Conclusions: Serum and plasma performed similarly for the majority of the analytes. Serum showed a slight advantage in predicting extreme body composition phenotypes in postmenopausal women using parallel evaluation of analytes.


Corresponding author: Jennifer W. Bea, Arizona Cancer Center, University of Arizona, 1515 N. Campbell Ave., Tucson, AZ 85724, USA Phone: +520-626-0912, Fax: +520-626-5348

Received: 2010-7-8
Accepted: 2010-11-22
Published Online: 2011-03-02
Published in Print: 2011-05-01

©2011 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
  3. Circulating macrocomplexes: old wine in new bottles?
  4. Review
  5. Laboratory assessment of new anticoagulants
  6. Minireviews
  7. Biomarkers in Alzheimer’s disease
  8. Analytical variability in sport hematology: its importance in an antidoping setting
  9. The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
  10. Opinion Paper
  11. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
  12. Genetics and Molecular Diagnostics
  13. Genetic variability of the fructosamine 3-kinase gene in diabetic patients
  14. Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
  15. Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
  16. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quality Indicators in Laboratory Medicine: from theory to practice
  19. Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
  20. Human growth hormone (GH) immunoassay: standardization and clinical implications
  21. Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
  22. Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
  23. Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
  24. Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
  25. Cancer Diagnostics
  26. Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
  27. Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
  28. Infectious Diseases
  29. Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
  30. Cardiovascular Diseases
  31. Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
  32. High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
  33. An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
  34. The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
  35. False positive troponin result caused by a true macrotroponin
  36. Letters to the Editor
  37. Patient safety: patient identification wristband errors
  38. Prevalence of hemolytic specimens referred for arterial blood gas analysis
  39. “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
  40. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.122/html
Scroll to top button